Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACkER trial of triple versus dual inhaled therapy in COPD patients with asthma-like features
NL-OMON60706Phase 4Completed
- Sponsor
- General Practitioners Research Institute
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of beclomethasone dipropionate, glycopyrronium and formoterol in chronic obstructive pulmonary disease (COPD), sponsored by General Practitioners Research Institute. Started Feb 2020; status: completed.
02
Drugs
beclomethasone dipropionateglycopyrroniumformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON60706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60706.